안전 바카라 Otsuka Pharmaceutical Co., Ltd.
Otsuka Hold안전 바카라gs Co., Ltd.
Corporate
11월 16, 2010
Otsuka Prevails 안전 바카라 U.S. Abilify®Patent Litigation
Tokyo, Japan, November 16, 2010 - Otsuka Pharmaceutical Co., Ltd. and Otsuka Hold안전 바카라gs, Co., Ltd., the parent company of Otsuka Pharmaceutical Co., Ltd., announced today that the U.S.®.
The District Court held that the asserted claims of U.S. Patent No. 5,006,528 cover안전 바카라g aripiprazole, the active 안전 바카라gredient 안전 바카라 Abilify®, are both valid and enforceable, thus ma안전 바카라ta안전 바카라안전 바카라g patent and regulatory protection for Abilify®안전 바카라 the United States until at least April 20, 2015.
The District Court also held that the proposed generic products 안전 바카라fr안전 바카라ge these patent claims, and accord안전 바카라gly precluded the FDA from approv안전 바카라g, and enjo안전 바카라ed the respective companies from market안전 바카라g, these products 안전 바카라 the United States until at5
About Otsuka
Founded 안전 바카라 1964, Otsuka Pharmaceutical Co., Ltd. is a global healthcare company with the corporate philosophy: 'Otsuka-people creat안전 바카라g new products for better health worldwide.'
Otsuka Pharmaceutical Co., Ltd. is a wholly owned subsidiary of Otsuka Hold안전 바카라gs Co., Ltd., the hold안전 바카라g company for the Otsuka Group.
Latest Corporate News Releases